There are anecdotal reports of adverse effects such as injection site pain, anxiety, insomnia, headaches, dizziness, and gastrointestinal discomfort, but these are not well-documented in clinical studies
(ATP)
Increases in resting heart rate are a recognised class effect of incretin-based therapies and have been reported with GLP-1 receptor agonists more broadly, as reflected in the Summary of Product Characteristics (SmPC) for licensed agents such as semaglutide (Wegovy) and liraglutide (Saxenda)
Soil biota are involved in soil organic matter (SOM) breakdown, mineralization, humus formation, nutrient acquisition and cycling, plant disease suppression, formation and stabilization of soil aggregates and maintaining or enhancing soil productivity [28, 34,35,36,37,38]